171 related articles for article (PubMed ID: 33276260)
21. Deep Learning of Rhabdomyosarcoma Pathology Images for Classification and Survival Outcome Prediction.
Zhang X; Wang S; Rudzinski ER; Agarwal S; Rong R; Barkauskas DA; Daescu O; Furman Cline L; Venkatramani R; Xie Y; Xiao G; Leavey P
Am J Pathol; 2022 Jun; 192(6):917-925. PubMed ID: 35390316
[TBL] [Abstract][Full Text] [Related]
22. Rhabdomyosarcoma of the head and neck: impact of demographic and clinicopathologic factors on survival.
Lee RJ; Lee KK; Lin T; Arshi A; Lee SA; Christensen RE
Oral Surg Oral Med Oral Pathol Oral Radiol; 2017 Sep; 124(3):271-279. PubMed ID: 28732698
[TBL] [Abstract][Full Text] [Related]
23. Focusing on organ preservation and function: paradigm shifts in the treatment of pediatric genitourinary rhabdomyosarcoma.
Shapiro DD; Harel M; Ferrer F; McKenna PH
Int Urol Nephrol; 2016 Jul; 48(7):1009-13. PubMed ID: 27068815
[TBL] [Abstract][Full Text] [Related]
24. Deep-learning model for predicting the survival of rectal adenocarcinoma patients based on a surveillance, epidemiology, and end results analysis.
Yu H; Huang T; Feng B; Lyu J
BMC Cancer; 2022 Feb; 22(1):210. PubMed ID: 35216571
[TBL] [Abstract][Full Text] [Related]
25. Increased lymph node ratio predicts poor survival in pediatric rhabdomyosarcoma.
Brady AC; Rao KA; Lane R; Garvin L; Sola JE; Perez EA
J Pediatr Surg; 2020 Mar; 55(3):369-375. PubMed ID: 31706606
[TBL] [Abstract][Full Text] [Related]
26. Improved outcome for patients with middle ear rhabdomyosarcoma: a children's oncology group study.
Hawkins DS; Anderson JR; Paidas CN; Wharam MD; Qualman SJ; Pappo AS; Scott Baker K; Crist WM
J Clin Oncol; 2001 Jun; 19(12):3073-9. PubMed ID: 11408504
[TBL] [Abstract][Full Text] [Related]
27. Prognostic determinants and treatment outcomes analysis of osteosarcoma and Ewing sarcoma of the spine.
Arshi A; Sharim J; Park DY; Park HY; Yazdanshenas H; Bernthal NM; Shamie AN
Spine J; 2017 May; 17(5):645-655. PubMed ID: 27856382
[TBL] [Abstract][Full Text] [Related]
28. Explainable deep learning-based survival prediction for non-small cell lung cancer patients undergoing radical radiotherapy.
Astley JR; Reilly JM; Robinson S; Wild JM; Hatton MQ; Tahir BA
Radiother Oncol; 2024 Apr; 193():110084. PubMed ID: 38244779
[TBL] [Abstract][Full Text] [Related]
29. Lymph Node Sampling and Survival in Child and Adolescent Extremity Soft-Tissue Sarcoma.
Brady AC; Picado O; Tashiro J; Sola JE; Perez EA
J Surg Res; 2019 Sep; 241():205-214. PubMed ID: 31028942
[TBL] [Abstract][Full Text] [Related]
30. Comparing adult and pediatric rhabdomyosarcoma in the surveillance, epidemiology and end results program, 1973 to 2005: an analysis of 2,600 patients.
Sultan I; Qaddoumi I; Yaser S; Rodriguez-Galindo C; Ferrari A
J Clin Oncol; 2009 Jul; 27(20):3391-7. PubMed ID: 19398574
[TBL] [Abstract][Full Text] [Related]
31. Application of a novel machine learning framework for predicting non-metastatic prostate cancer-specific mortality in men using the Surveillance, Epidemiology, and End Results (SEER) database.
Lee C; Light A; Alaa A; Thurtle D; van der Schaar M; Gnanapragasam VJ
Lancet Digit Health; 2021 Mar; 3(3):e158-e165. PubMed ID: 33549512
[TBL] [Abstract][Full Text] [Related]
32. Score for the Survival Probability of Patients With Orbital Rhabdomyosarcoma After Surgery: A Long-Term and Large Cohort Study.
Zhang Y; He C; Lian Y; Xiao H
Front Oncol; 2020; 10():1590. PubMed ID: 32974196
[TBL] [Abstract][Full Text] [Related]
33. Deep learning models for predicting the survival of patients with chondrosarcoma based on a surveillance, epidemiology, and end results analysis.
Yan L; Gao N; Ai F; Zhao Y; Kang Y; Chen J; Weng Y
Front Oncol; 2022; 12():967758. PubMed ID: 36072795
[TBL] [Abstract][Full Text] [Related]
34. Does the SORG Algorithm Predict 5-year Survival in Patients with Chondrosarcoma? An External Validation.
Bongers MER; Thio QCBS; Karhade AV; Stor ML; Raskin KA; Lozano Calderon SA; DeLaney TF; Ferrone ML; Schwab JH
Clin Orthop Relat Res; 2019 Oct; 477(10):2296-2303. PubMed ID: 31107338
[TBL] [Abstract][Full Text] [Related]
35. Head and neck rhabdomyosarcoma: a critical analysis of population-based incidence and survival data.
Turner JH; Richmon JD
Otolaryngol Head Neck Surg; 2011 Dec; 145(6):967-73. PubMed ID: 21873599
[TBL] [Abstract][Full Text] [Related]
36. Prognostic factors of pediatric pelvic and genitourinary rhabdomyosarcoma: An analysis based on SEER database.
Wu J; Shou X; Cai J; Mao J; Qian J; Wang J; Ni S
Front Oncol; 2022; 12():992738. PubMed ID: 36132132
[TBL] [Abstract][Full Text] [Related]
37. European intergroup studies (MMT4-89 and MMT4-91) on childhood metastatic rhabdomyosarcoma: final results and analysis of prognostic factors.
Carli M; Colombatti R; Oberlin O; Bisogno G; Treuner J; Koscielniak E; Tridello G; Garaventa A; Pinkerton R; Stevens M
J Clin Oncol; 2004 Dec; 22(23):4787-94. PubMed ID: 15570080
[TBL] [Abstract][Full Text] [Related]
38. Sarcoma of the prostate: a single institutional review.
Janet NL; May AW; Akins RS
Am J Clin Oncol; 2009 Feb; 32(1):27-9. PubMed ID: 19194120
[TBL] [Abstract][Full Text] [Related]
39. The impact of surgical excision in chest wall rhabdomyosarcoma: a report from the Children's Oncology Group.
Hayes-Jordan A; Stoner JA; Anderson JR; Rodeberg D; Weiner G; Meyer WH; Hawkins DS; Arndt CA; Paidas C;
J Pediatr Surg; 2008 May; 43(5):831-6. PubMed ID: 18485948
[TBL] [Abstract][Full Text] [Related]
40. Rhabdomyosarcoma of the lower female genital tract: an analysis of 144 cases.
Nasioudis D; Alevizakos M; Chapman-Davis E; Witkin SS; Holcomb K
Arch Gynecol Obstet; 2017 Aug; 296(2):327-334. PubMed ID: 28634755
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
